6.06
-0.615(-9.22%)
Currency In USD
| Previous Close | 6.67 |
| Open | 6.52 |
| Day High | 6.54 |
| Day Low | 6.05 |
| 52-Week High | 22.25 |
| 52-Week Low | 5.54 |
| Volume | 193,996.69 |
| Average Volume | 379,011 |
| Market Cap | 112.87M |
| PE | 605.5 |
| EPS | 0.01 |
| Moving Average 50 Days | 10.26 |
| Moving Average 200 Days | 14.36 |
| Change | -0.62 |
If you invested $1000 in OptimizeRx Corporation (OPRX) 10 years ago, it would be worth $2,170.25 as of March 12, 2026 at a share price of $6.055. Whereas If you bought $1000 worth of OptimizeRx Corporation (OPRX) shares 5 years ago, it would be worth $133.69 as of March 12, 2026 at a share price of $6.055.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
GlobeNewswire Inc.
Feb 05, 2026 1:00 PM GMT
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
GlobeNewswire Inc.
Jan 07, 2026 1:00 PM GMT
Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectivenessWALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
GlobeNewswire Inc.
Dec 17, 2025 9:30 AM GMT
Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37%WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of hea